Drug Information

Drug General Information
Drug ID
D0Y4BO
Former ID
DIB007804
Drug Name
ABI-013
Synonyms
Nab-CY196; Nab-ABI-139; Nanoparticle albumin-bound ABI-139 (injectable, cancer), Abraxis; Nanoparticle albumin-bound ABI-139 (injectable, cancer), Celgene
Drug Type
Antibody
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Preclinical [549895]
Company
Abraxis BioScience Inc
Target and Pathway
Target(s) Tubulin Target Info [549756]
References
Ref 549895Clinical pipeline report, company report or official report of Celgene Corporation.
Ref 549756Cardiovascular and CNS safety profile of ABI-013, a novel nanoparticle albumin-bound (nab) analog of docetaxel. Cancer Research. 01/2011; 70(8 Supplement):2617-2617.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.